Analytical Data
-
Gene name
FOXD1
- Application
-
Alternative Names
FREAC4; FOX-D1; FKHL8; Forkhead-related protein FKHL8; Forkhead-related transcription factor 4
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16676
-
Expression Region
Met1~Asn176
-
Molecular Weight
48kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FOXD1, a member of the forkhead family of transcription factors, plays a crucial role in various biological processes, including organ development, cellular differentiation, and tissue homeostasis. Its expression is notably detected in the kidneys, suggesting a significant involvement in renal development and function. Recent studies have linked FOXD1 to various pathological conditions such as kidney diseases and cancers, highlighting its potential as a therapeutic target. The interest in the recombinant expression of FOXD1 protein stems from its utility in understanding the mechanistic pathways underlying its function and regulation. By generating recombinant FOXD1, researchers aim to explore its interaction with other proteins, identify downstream target genes, and elucidate its role in disease progression. Additionally, characterizing FOXD1 in a controlled environment allows for the development of specific inhibitors or modulators that could have therapeutic implications. Overall, the study of FOXD1 recombinant protein serves not only to expand our comprehension of forkhead transcription factors but also to pave the way for novel strategies in treating related diseases.
